People's Pharmacy

For more up-to-date information on drugs, herbs and home remedies visit The People's Pharmacy Home Site at peoplespharmacy.us

FDA On The Hotseat Because Of Safety Concerns

Posting Date: 03/21/2005

According to the old proverb, ?He who pays the piper calls the tune.? FDA officials are now facing the music. They must answer to the American public, the people who really pay the bills.

For decades Congress has allocated billions of taxpayer dollars to the FDA to ensure that our medications are safe and effective. For the most part the agency has been left on its own to carry out this mission. But now Americans are worried about confusing headlines regarding the safety of Vioxx and a variety of other medicines.

FDA officials have been called on the carpet by Senators anxious to get to the bottom of the pain reliever puzzle. Some wonder if FDA can police drug safety on its own. Experts have proposed a separate body, independent of the agency, for this task. FDA officials do not want to give up this responsibility.

But consumers are nervous. In a recent survey, only 14 percent said they have great confidence in the FDA?s ability to safeguard the country?s drug supply. The majority of consumers in this poll favor an independent drug watchdog agency.

The FDA has maintained for months that it did nothing wrong with respect to its oversight of Vioxx and other COX-2 inhibitors like Celebrex or Bextra. But during Senate hearings, one agency official recently admitted to ?lapses.?

Dr. Sandra Kweder, deputy director of the Office of New Drugs, bemoaned that it took the agency and the manufacturer more than a year to negotiate wording on heart risk for the Vioxx label. The other shortcoming she mentioned was a failure to get doctors to pay close attention to these dangers.

It?s hardly any wonder patients and physicians were so enthusiastic about Vioxx and Celebrex. The advertising on television and in magazines was compelling.

Experts have criticized this ?direct to consumer? (DTC) advertising. Many physicians feel it puts them under inappropriate pressure to prescribe. And the public is getting weary of watching commercials for erectile dysfunction drugs or other prescription products.